Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ross Camidge

Showing results (71-80 of 317) with videos related to

Pageof 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLCScott A Kono, Michael Weyant, Wilbur Franklin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Crizotinib effects on creatinine and non-creatinine-based measures of glomerular filtration rateD Ross Camidge, Evelyn M Brosnan, Chamath DeSilva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2020
Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced NSCLCTerry L Ng, Narayana Narasimhan, Neeraj Gupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial RegistryCaroline E McCoach, Eamon M Berge, Xian Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.
Clinical Lung Cancer|July 31, 2021
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor TherapyDavid Chun Cheong Tsui, Dara Aisner, Hala Nijmeh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth makingTodd M Erickson, John R Koeppe, York E Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2017
Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung CancerEmily R York, Marileila Varella-Garcia, Tami J Bang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
Pageof 32

Showing results (71-80 of 317) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLCScott A Kono, Michael Weyant, Wilbur Franklin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Crizotinib effects on creatinine and non-creatinine-based measures of glomerular filtration rateD Ross Camidge, Evelyn M Brosnan, Chamath DeSilva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2020
Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced NSCLCTerry L Ng, Narayana Narasimhan, Neeraj Gupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial RegistryCaroline E McCoach, Eamon M Berge, Xian Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.
Clinical Lung Cancer|July 31, 2021
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor TherapyDavid Chun Cheong Tsui, Dara Aisner, Hala Nijmeh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth makingTodd M Erickson, John R Koeppe, York E Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2017
Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung CancerEmily R York, Marileila Varella-Garcia, Tami J Bang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
Pageof 32